Circulating levels of IgM anti-CD64, an immunosuppressive antibody recently identified in long-term stable multiple sclerosis (MS) patients, were found to fluctuate over time in MS patients. Antibody-positive patients showed a significantly lower annualized relapse rate value as well as reached sustained disability worsening and had a relapse in a significantly longer median time than those without antibody. Disease-modifying therapies (DMTs) only were the covariate influencing both the relapse occurrence and the disability accrual. Serum IgM anti-CD64 levels are associated with maintenance of clinical stability in MS and may be tested as a candidate biomarker predictive of benign course and favourable long-term response to DMTs treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2019.03.005DOI Listing

Publication Analysis

Top Keywords

favourable long-term
8
multiple sclerosis
8
sclerosis patients
8
igm anti-cd64
8
association circulating
4
circulating anti-cd64
4
anti-cd64 igm
4
igm levels
4
levels favourable
4
long-term clinical
4

Similar Publications

An Iterative Design Method for Advancing Air Traffic Control and Management Training Through Immersive VFR 3D Map Visualization.

IISE Trans Occup Ergon Hum Factors

January 2025

The Bradley Department of Electrical and Computer Engineering, College of Engineering, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.

OCCUPATIONAL APPLICATIONSInnovative tools that align with modern learners' preferences are essential for training in safety-critical professions like Air Traffic Control/Management. This study evaluated a Virtual Reality Visual Flight Rules 3D Map Visualization Tool designed to meet the Federal Aviation Administration's (FAA) modernization goals. The tool immerses trainee in contextually accurate environments, enhancing engagement and self-paced learning.

View Article and Find Full Text PDF

Phosphodiesterase-4 (PDE4) is involved in the synthesis of inflammatory cytokines that mediate several chronic inflammatory disorders, including psoriasis and atopic dermatitis. In recent years, the therapeutic armamentarium in dermatology has expanded with the introduction of PDE4 inhibitors, both in oral and topical formulations. PDE4 inhibitors have gained increasing interest due to their remarkable safety record and ease of prescription, as evidenced by the recent influx of literature detailing its off-label uses.

View Article and Find Full Text PDF

: Alpha radionuclide therapy has emerged as a promising novel strategy for cancer treatment; however, the therapeutic potential of Ac-labeled peptides in pancreatic cancer remains uninvestigated. : In the cytotoxicity study, tumor cells were incubated with Ac-DOTA-RGD. DNA damage responses (γH2AX and 53BP1) were detected using flowcytometry or immunohistochemistry analysis.

View Article and Find Full Text PDF

Background: Preterm infants (PIs) are more susceptible to neurodevelopmental impairment compared with term newborns. Adequate postnatal growth has been associated with improved neurocognitive outcomes; therefore, optimization of nutrition may positively impact the neurodevelopment of PIs.

Objective: This study focused on macronutrient parenteral nutrition (PN) intake during the Neonatal Intensive Care Unit stay and their associations with neurodevelopmental outcomes in PIs in the first two years of life.

View Article and Find Full Text PDF

: This study aims to describe and analyze the indications and clinical results of total TMJ replacement in participants with degenerative and/or inflammatory joint diseases, defining patient and intervention conditions. : A systematic review was conducted according to the Cochrane Handbook for Systematic Reviews of Intervention and reported according to the PRISMA Items update. The search strategy was from 1997 to July 2024 in Pubmed, Embase, Scopus, and Web of Science.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!